SynthesisFrontiers in pharmacology2022

Using proton pump inhibitors increases the risk of hepato-biliary-pancreatic cancer. A systematic review and meta-analysis.

Wence Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.